chr6-169773059-A-G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_018341.3(ERMARD):​c.1234-260A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.255 in 377,848 control chromosomes in the GnomAD database, including 13,598 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.28 ( 6787 hom., cov: 32)
Exomes 𝑓: 0.23 ( 6811 hom. )

Consequence

ERMARD
NM_018341.3 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.63

Publications

5 publications found
Variant links:
Genes affected
ERMARD (HGNC:21056): (ER membrane associated RNA degradation) The protein encoded by this gene contains 2 transmembrane domains near the C-terminus and is localized in the endoplasmic reticulum. Knockout of this gene in developing rat brain showed that it may be involved in neuronal migration. Mutations in this gene are associated with periventricular nodular heterotopia-6 (PVNH6). Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2013]
ERMARD Gene-Disease associations (from GenCC):
  • periventricular nodular heterotopia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • periventricular nodular heterotopia 6
    Inheritance: AD, Unknown Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 6-169773059-A-G is Benign according to our data. Variant chr6-169773059-A-G is described in ClinVar as Benign. ClinVar VariationId is 668133.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.414 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ERMARDNM_018341.3 linkc.1234-260A>G intron_variant Intron 12 of 17 ENST00000366773.8 NP_060811.1 Q5T6L9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ERMARDENST00000366773.8 linkc.1234-260A>G intron_variant Intron 12 of 17 2 NM_018341.3 ENSP00000355735.3 Q5T6L9-1

Frequencies

GnomAD3 genomes
AF:
0.284
AC:
43035
AN:
151310
Hom.:
6762
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.419
Gnomad AMI
AF:
0.127
Gnomad AMR
AF:
0.268
Gnomad ASJ
AF:
0.263
Gnomad EAS
AF:
0.326
Gnomad SAS
AF:
0.295
Gnomad FIN
AF:
0.162
Gnomad MID
AF:
0.258
Gnomad NFE
AF:
0.224
Gnomad OTH
AF:
0.287
GnomAD4 exome
AF:
0.235
AC:
53184
AN:
226418
Hom.:
6811
Cov.:
0
AF XY:
0.235
AC XY:
27128
AN XY:
115654
show subpopulations
African (AFR)
AF:
0.407
AC:
2819
AN:
6934
American (AMR)
AF:
0.279
AC:
2288
AN:
8214
Ashkenazi Jewish (ASJ)
AF:
0.267
AC:
2288
AN:
8580
East Asian (EAS)
AF:
0.326
AC:
6598
AN:
20236
South Asian (SAS)
AF:
0.260
AC:
1126
AN:
4330
European-Finnish (FIN)
AF:
0.168
AC:
2762
AN:
16416
Middle Eastern (MID)
AF:
0.220
AC:
259
AN:
1178
European-Non Finnish (NFE)
AF:
0.216
AC:
31420
AN:
145666
Other (OTH)
AF:
0.244
AC:
3624
AN:
14864
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
1838
3677
5515
7354
9192
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
204
408
612
816
1020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.285
AC:
43120
AN:
151430
Hom.:
6787
Cov.:
32
AF XY:
0.282
AC XY:
20859
AN XY:
73922
show subpopulations
African (AFR)
AF:
0.419
AC:
17312
AN:
41282
American (AMR)
AF:
0.268
AC:
4076
AN:
15226
Ashkenazi Jewish (ASJ)
AF:
0.263
AC:
911
AN:
3464
East Asian (EAS)
AF:
0.328
AC:
1683
AN:
5138
South Asian (SAS)
AF:
0.297
AC:
1421
AN:
4790
European-Finnish (FIN)
AF:
0.162
AC:
1681
AN:
10354
Middle Eastern (MID)
AF:
0.264
AC:
76
AN:
288
European-Non Finnish (NFE)
AF:
0.224
AC:
15239
AN:
67888
Other (OTH)
AF:
0.289
AC:
606
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1503
3006
4510
6013
7516
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
438
876
1314
1752
2190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.251
Hom.:
655
Bravo
AF:
0.298

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.083
DANN
Benign
0.49
PhyloP100
-1.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4145078; hg19: chr6-170173155; COSMIC: COSV64647797; COSMIC: COSV64647797; API